The expectation is for Q2 earnings to increase by +5.1% from the same period last year on +3.8% higher revenues. This will be ...

The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co. (LLY), The Home ...

COST, AZO, and ORCL results kick off Q2 earnings as tech estimates stabilize and tariff pressures weigh on broader revisions.

Oracle (ORCL) delivered earnings and revenue surprises of 3.66% and 2.31%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?

Based on Zacks' estimates, Adobe’s Q2 sales are thought to have increased 9% to $5.79 billion versus $5.31 billion in the ...

Salesforce, Inc. CRM is currently trading at an attractive valuation, with its forward 12-month price-to-earnings (P/E) ratio ...

Detailed price information for Palantir Technologies Inc Cl A (PLTR-Q) from The Globe and Mail including charting and trades.

Zacks spotlights ORCL, NVO, LIN, NVEC and CPSH for their strategic growth plays, from AI cloud to medtech sensing and advanced materials.

ORCL gains on strong cloud momentum, while NVO battles obesity headwinds and LIN leans on $10B backlog for growth.

Oracle closed at $169.14, rising 1.54% and outperforming all major indexes, including the S&P 500. Over the past month, ...

The latest trading day saw Oracle (ORCL) settling at $169.14, representing a +1.54% change from its previous close.

Over the past month, there's been no change in the Zacks Consensus EPS estimate. At present, Oracle boasts a Zacks Rank of #3 (Hold). In the context of valuation, Oracle is at present trading with ...